speb/financial-data huggingface dataset:
BEAT income_statement (quarterly, 2025-03-31) — Net Income: -5484000.00
BEAT income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -5484000.00
BEAT income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: -5484000.00
BEAT income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -5484000.00
BEAT income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -5484000.00
BEAT cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: -5484000.00
BEAT income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: -5484000.00
BEAT income_statement (quarterly, 2025-03-31) — Net Interest Income: 20000.00
BEAT cash_flow (quarterly, 2025-03-31) — Net Investment Purchase And Sale: -3760000.00
BEAT income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: 20000.00
BEAT balance_sheet (quarterly, 2025-03-31) — Net PPE: 443000.00
BEAT cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: 0.00
BEAT balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 7529000.00
BEAT income_statement (quarterly, 2025-03-31) — Normalized EBITDA: -5497000.00
BEAT income_statement (quarterly, 2025-03-31) — Normalized Income: -5484000.00
BEAT cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: -4477000.00
BEAT income_statement (quarterly, 2025-03-31) — Operating Income: -5504000.00
BEAT income_statement (quarterly, 2025-03-31) — Operating Revenue: 0.00
BEAT balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 33734548.00
BEAT balance_sheet (quarterly, 2025-03-31) — Other Current Assets: 458000.00
BEAT income_statement (quarterly, 2025-03-31) — Other Gand A: 2012000.00
BEAT balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 56000.00
BEAT balance_sheet (quarterly, 2025-03-31) — Other Short Term Investments: 3760000.00
BEAT balance_sheet (quarterly, 2025-03-31) — Payables: 523000.00
BEAT balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 1578000.00
BEAT balance_sheet (quarterly, 2025-03-31) — Preferred Stock: 0.00
BEAT income_statement (quarterly, 2025-03-31) — Pretax Income: -5484000.00
BEAT cash_flow (quarterly, 2025-03-31) — Purchase Of Investment: -3760000.00
BEAT cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: 0.00
BEAT income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 7000.00
BEAT income_statement (quarterly, 2025-03-31) — Research And Development: 3492000.00
BEAT balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -61757000.00
BEAT income_statement (quarterly, 2025-03-31) — Selling General And Administration: 2012000.00
BEAT balance_sheet (quarterly, 2025-03-31) — Share Issued: 33734548.00
BEAT cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 1109000.00
BEAT balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 7529000.00
BEAT balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 7529000.00
BEAT income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 0.00
BEAT income_statement (quarterly, 2025-03-31) — Tax Provision: 0.00
BEAT income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.00
BEAT balance_sheet (quarterly, 2025-03-31) — Total Assets: 9107000.00
BEAT balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 7529000.00
BEAT balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 7529000.00
BEAT income_statement (quarterly, 2025-03-31) — Total Expenses: 5504000.00
BEAT balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 1578000.00
BEAT balance_sheet (quarterly, 2025-03-31) — Total Non Current Assets: 499000.00
BEAT balance_sheet (quarterly, 2025-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
BEAT income_statement (quarterly, 2025-03-31) — Total Operating Income As Reported: -5504000.00
BEAT balance_sheet (quarterly, 2025-03-31) — Working Capital: 7030000.00
BEAT income_statement (quarterly, 2025-06-30) — +Operating Expense: 5037000.00
BEAT income_statement (quarterly, 2025-06-30) — +Total Revenue: 0.00
BEAT balance_sheet (quarterly, 2025-06-30) — Accounts Payable: 814000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Additional Paid In Capital: 70909000.00
BEAT income_statement (quarterly, 2025-06-30) — Basic Average Shares: 33834950.00
BEAT income_statement (quarterly, 2025-06-30) — Basic EPS: -0.15
BEAT cash_flow (quarterly, 2025-06-30) — Beginning Cash Position: 4446000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Capital Stock: 4000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Cash And Cash Equivalents: 3256000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Cash Cash Equivalents And Short Term Investments: 5053000.00
BEAT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Financing Activities: 450000.00
BEAT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Investing Activities: 1861000.00
BEAT cash_flow (quarterly, 2025-06-30) — Cash Flow From Continuing Operating Activities: -3445000.00
BEAT cash_flow (quarterly, 2025-06-30) — Change In Payables And Accrued Expense: 194000.00
BEAT cash_flow (quarterly, 2025-06-30) — Change In Prepaid Assets: 150000.00
BEAT cash_flow (quarterly, 2025-06-30) — Change In Working Capital: 344000.00
BEAT cash_flow (quarterly, 2025-06-30) — Changes In Cash: -1134000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Common Stock: 4000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Common Stock Equity: 4182000.00
BEAT cash_flow (quarterly, 2025-06-30) — Common Stock Issuance: 450000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Construction In Progress: 375000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Current Accrued Expenses: 985000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Current Assets: 5361000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Current Liabilities: 1799000.00
BEAT cash_flow (quarterly, 2025-06-30) — Depreciation: 8000.00
BEAT cash_flow (quarterly, 2025-06-30) — Depreciation Amortization Depletion: 8000.00
BEAT cash_flow (quarterly, 2025-06-30) — Depreciation And Amortization: 8000.00
BEAT income_statement (quarterly, 2025-06-30) — Diluted Average Shares: 33834950.00
BEAT income_statement (quarterly, 2025-06-30) — Diluted EPS: -0.15
BEAT income_statement (quarterly, 2025-06-30) — Diluted NI Availto Com Stockholders: -4974000.00
BEAT income_statement (quarterly, 2025-06-30) — EBIT: -5037000.00
BEAT income_statement (quarterly, 2025-06-30) — EBITDA: -5029000.00
BEAT cash_flow (quarterly, 2025-06-30) — End Cash Position: 3312000.00
BEAT cash_flow (quarterly, 2025-06-30) — Financing Cash Flow: 450000.00
BEAT cash_flow (quarterly, 2025-06-30) — Free Cash Flow: -3547000.00
BEAT income_statement (quarterly, 2025-06-30) — General And Administrative Expense: 1711000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Gross PPE: 564000.00
BEAT cash_flow (quarterly, 2025-06-30) — Income Tax Paid Supplemental Data: 0.00
BEAT income_statement (quarterly, 2025-06-30) — Interest Income: 63000.00
BEAT income_statement (quarterly, 2025-06-30) — Interest Income Non Operating: 63000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Invested Capital: 4182000.00
BEAT cash_flow (quarterly, 2025-06-30) — Investing Cash Flow: 1861000.00
BEAT cash_flow (quarterly, 2025-06-30) — Issuance Of Capital Stock: 450000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Machinery Furniture Equipment: 189000.00
BEAT cash_flow (quarterly, 2025-06-30) — Net Common Stock Issuance: 450000.00
BEAT income_statement (quarterly, 2025-06-30) — Net Income: -4974000.00
BEAT income_statement (quarterly, 2025-06-30) — Net Income Common Stockholders: -4974000.00
BEAT income_statement (quarterly, 2025-06-30) — Net Income Continuous Operations: -4974000.00
BEAT income_statement (quarterly, 2025-06-30) — Net Income From Continuing And Discontinued Operation: -4974000.00
BEAT income_statement (quarterly, 2025-06-30) — Net Income From Continuing Operation Net Minority Interest: -4974000.00
BEAT cash_flow (quarterly, 2025-06-30) — Net Income From Continuing Operations: -4974000.00
BEAT income_statement (quarterly, 2025-06-30) — Net Income Including Noncontrolling Interests: -4974000.00
BEAT income_statement (quarterly, 2025-06-30) — Net Interest Income: 63000.00
BEAT cash_flow (quarterly, 2025-06-30) — Net Investment Purchase And Sale: 1963000.00
BEAT income_statement (quarterly, 2025-06-30) — Net Non Operating Interest Income Expense: 63000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Net PPE: 564000.00
BEAT cash_flow (quarterly, 2025-06-30) — Net PPE Purchase And Sale: -102000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Net Tangible Assets: 4182000.00
BEAT income_statement (quarterly, 2025-06-30) — Normalized EBITDA: -5029000.00
BEAT income_statement (quarterly, 2025-06-30) — Normalized Income: -4974000.00
BEAT cash_flow (quarterly, 2025-06-30) — Operating Cash Flow: -3445000.00
BEAT income_statement (quarterly, 2025-06-30) — Operating Income: -5037000.00
BEAT income_statement (quarterly, 2025-06-30) — Operating Revenue: 0.00
BEAT balance_sheet (quarterly, 2025-06-30) — Ordinary Shares Number: 34020340.00
BEAT balance_sheet (quarterly, 2025-06-30) — Other Current Assets: 308000.00
BEAT income_statement (quarterly, 2025-06-30) — Other Gand A: 1711000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Other Non Current Assets: 56000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Other Short Term Investments: 1797000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Payables: 814000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Payables And Accrued Expenses: 1799000.00
BEAT income_statement (quarterly, 2025-06-30) — Pretax Income: -4974000.00
BEAT cash_flow (quarterly, 2025-06-30) — Purchase Of Investment: 0.00
BEAT cash_flow (quarterly, 2025-06-30) — Purchase Of PPE: -102000.00
BEAT income_statement (quarterly, 2025-06-30) — Reconciled Depreciation: 8000.00
BEAT income_statement (quarterly, 2025-06-30) — Research And Development: 3326000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Retained Earnings: -66731000.00
BEAT income_statement (quarterly, 2025-06-30) — Selling General And Administration: 1711000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Share Issued: 34020340.00
BEAT cash_flow (quarterly, 2025-06-30) — Stock Based Compensation: 1177000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Stockholders Equity: 4182000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Tangible Book Value: 4182000.00
BEAT income_statement (quarterly, 2025-06-30) — Tax Effect Of Unusual Items: 0.00
BEAT income_statement (quarterly, 2025-06-30) — Tax Provision: 0.00
BEAT income_statement (quarterly, 2025-06-30) — Tax Rate For Calcs: 0.00
BEAT balance_sheet (quarterly, 2025-06-30) — Total Assets: 5981000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Total Capitalization: 4182000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Total Equity Gross Minority Interest: 4182000.00
BEAT income_statement (quarterly, 2025-06-30) — Total Expenses: 5037000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Total Liabilities Net Minority Interest: 1799000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Total Non Current Assets: 620000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Total Non Current Liabilities Net Minority Interest: 0.00
BEAT income_statement (quarterly, 2025-06-30) — Total Operating Income As Reported: -5037000.00
BEAT balance_sheet (quarterly, 2025-06-30) — Working Capital: 3562000.00
BEAT income_statement (quarterly, 2025-09-30) — +Operating Expense: 5290000.00
BEAT income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
BEAT balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1021000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 72388000.00
BEAT income_statement (quarterly, 2025-09-30) — Basic Average Shares: 34396431.00
BEAT income_statement (quarterly, 2025-09-30) — Basic EPS: -0.15
BEAT cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 3312000.00
BEAT cash_flow (quarterly, 2025-09-30) — Capital Expenditure: -82000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Capital Stock: 4000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 1856000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 1856000.00
BEAT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 45000.00
BEAT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Investing Activities: 1715000.00
BEAT cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -3160000.00
BEAT cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 615000.00
BEAT cash_flow (quarterly, 2025-09-30) — Change In Prepaid Assets: 38000.00
BEAT cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 653000.00
BEAT cash_flow (quarterly, 2025-09-30) — Changes In Cash: -1400000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Common Stock: 4000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: 406000.00
BEAT cash_flow (quarterly, 2025-09-30) — Common Stock Issuance: 44000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Construction In Progress: 493000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 1449000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Current Assets: 2126000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 2470000.00
BEAT cash_flow (quarterly, 2025-09-30) — Depreciation: 8000.00
BEAT cash_flow (quarterly, 2025-09-30) — Depreciation Amortization Depletion: 8000.00
BEAT cash_flow (quarterly, 2025-09-30) — Depreciation And Amortization: 8000.00
BEAT income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 34396431.00
BEAT income_statement (quarterly, 2025-09-30) — Diluted EPS: -0.15
BEAT income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -5255000.00
BEAT income_statement (quarterly, 2025-09-30) — EBIT: -5290000.00
BEAT income_statement (quarterly, 2025-09-30) — EBITDA: -5282000.00
BEAT cash_flow (quarterly, 2025-09-30) — End Cash Position: 1912000.00
BEAT cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 45000.00
BEAT cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -3242000.00
BEAT income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 2012000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Gross PPE: 694000.00
BEAT cash_flow (quarterly, 2025-09-30) — Income Tax Paid Supplemental Data: 0.00
BEAT income_statement (quarterly, 2025-09-30) — Interest Income: 36000.00
BEAT income_statement (quarterly, 2025-09-30) — Interest Income Non Operating: 36000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Invested Capital: 406000.00
BEAT cash_flow (quarterly, 2025-09-30) — Investing Cash Flow: 1715000.00
BEAT cash_flow (quarterly, 2025-09-30) — Issuance Of Capital Stock: 44000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Machinery Furniture Equipment: 201000.00
BEAT cash_flow (quarterly, 2025-09-30) — Net Common Stock Issuance: 44000.00
BEAT income_statement (quarterly, 2025-09-30) — Net Income: -5255000.00
BEAT income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -5255000.00
BEAT income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -5255000.00
BEAT income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -5255000.00
BEAT income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -5255000.00
BEAT cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -5255000.00
BEAT income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -5255000.00
BEAT income_statement (quarterly, 2025-09-30) — Net Interest Income: 36000.00
BEAT cash_flow (quarterly, 2025-09-30) — Net Investment Purchase And Sale: 1797000.00
BEAT income_statement (quarterly, 2025-09-30) — Net Non Operating Interest Income Expense: 36000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Net PPE: 694000.00
BEAT cash_flow (quarterly, 2025-09-30) — Net PPE Purchase And Sale: -82000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: 406000.00
BEAT income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -5282000.00
BEAT income_statement (quarterly, 2025-09-30) — Normalized Income: -5255000.00
BEAT cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -3160000.00
BEAT income_statement (quarterly, 2025-09-30) — Operating Income: -5290000.00
BEAT income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
BEAT balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 34340727.00
BEAT balance_sheet (quarterly, 2025-09-30) — Other Current Assets: 270000.00
BEAT income_statement (quarterly, 2025-09-30) — Other Gand A: 2012000.00
BEAT income_statement (quarterly, 2025-09-30) — Other Income Expense: -1000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Other Non Current Assets: 56000.00
BEAT income_statement (quarterly, 2025-09-30) — Other Non Operating Income Expenses: -1000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Payables: 1021000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 2470000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
BEAT income_statement (quarterly, 2025-09-30) — Pretax Income: -5255000.00
BEAT cash_flow (quarterly, 2025-09-30) — Proceeds From Stock Option Exercised: 1000.00
BEAT cash_flow (quarterly, 2025-09-30) — Purchase Of Investment: 0.00
BEAT cash_flow (quarterly, 2025-09-30) — Purchase Of PPE: -82000.00
BEAT income_statement (quarterly, 2025-09-30) — Reconciled Depreciation: 8000.00
BEAT income_statement (quarterly, 2025-09-30) — Research And Development: 3278000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Retained Earnings: -71986000.00
BEAT cash_flow (quarterly, 2025-09-30) — Sale Of Investment: 1797000.00
BEAT income_statement (quarterly, 2025-09-30) — Selling General And Administration: 2012000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Share Issued: 34340727.00
BEAT cash_flow (quarterly, 2025-09-30) — Stock Based Compensation: 1434000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Stockholders Equity: 406000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Tangible Book Value: 406000.00
BEAT income_statement (quarterly, 2025-09-30) — Tax Effect Of Unusual Items: 0.00
BEAT income_statement (quarterly, 2025-09-30) — Tax Provision: 0.00
BEAT income_statement (quarterly, 2025-09-30) — Tax Rate For Calcs: 0.00
BEAT balance_sheet (quarterly, 2025-09-30) — Total Assets: 2876000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Total Capitalization: 406000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Total Equity Gross Minority Interest: 406000.00
BEAT income_statement (quarterly, 2025-09-30) — Total Expenses: 5290000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Total Liabilities Net Minority Interest: 2470000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Total Non Current Assets: 750000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Total Non Current Liabilities Net Minority Interest: 0.00
BEAT income_statement (quarterly, 2025-09-30) — Total Operating Income As Reported: -5290000.00
BEAT balance_sheet (quarterly, 2025-09-30) — Working Capital: -344000.00
BEAT income_statement (annual, 2025-12-31) — +Operating Expense: 21139000.00
BEAT income_statement (quarterly, 2025-12-31) — +Operating Expense: 5310000.00
BEAT income_statement (annual, 2025-12-31) — +Total Revenue: 0.00
BEAT income_statement (quarterly, 2025-12-31) — +Total Revenue: 0.00
BEAT balance_sheet (annual, 2025-12-31) — Accounts Payable: 1053000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Accounts Payable: 1053000.00
BEAT balance_sheet (annual, 2025-12-31) — Additional Paid In Capital: 79887000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Additional Paid In Capital: 79887000.00
BEAT income_statement (annual, 2025-12-31) — Basic Average Shares: 33710095.00
BEAT income_statement (annual, 2025-12-31) — Basic EPS: -0.62
BEAT cash_flow (annual, 2025-12-31) — Beginning Cash Position: 2433000.00
BEAT cash_flow (quarterly, 2025-12-31) — Beginning Cash Position: 1912000.00
BEAT cash_flow (annual, 2025-12-31) — Capital Expenditure: -600000.00
BEAT cash_flow (quarterly, 2025-12-31) — Capital Expenditure: -416000.00
BEAT balance_sheet (annual, 2025-12-31) — Capital Stock: 4000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Capital Stock: 4000.00
BEAT balance_sheet (annual, 2025-12-31) — Cash And Cash Equivalents: 4380000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Cash And Cash Equivalents: 4380000.00
BEAT balance_sheet (annual, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 4380000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Cash Cash Equivalents And Short Term Investments: 4380000.00
BEAT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Financing Activities: 16591000.00
BEAT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Financing Activities: 5846000.00
BEAT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Investing Activities: -600000.00
BEAT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Investing Activities: -416000.00
BEAT cash_flow (annual, 2025-12-31) — Cash Flow From Continuing Operating Activities: -13988000.00
BEAT cash_flow (quarterly, 2025-12-31) — Cash Flow From Continuing Operating Activities: -2906000.00
BEAT cash_flow (annual, 2025-12-31) — Change In Account Payable: 1526000.00
BEAT cash_flow (annual, 2025-12-31) — Change In Inventory: -103000.00
BEAT cash_flow (annual, 2025-12-31) — Change In Payable: 1526000.00
BEAT cash_flow (annual, 2025-12-31) — Change In Payables And Accrued Expense: 1526000.00
BEAT cash_flow (quarterly, 2025-12-31) — Change In Payables And Accrued Expense: 761000.00
BEAT cash_flow (annual, 2025-12-31) — Change In Prepaid Assets: 191000.00
BEAT cash_flow (quarterly, 2025-12-31) — Change In Prepaid Assets: 68000.00
BEAT cash_flow (annual, 2025-12-31) — Change In Working Capital: 1614000.00
BEAT cash_flow (quarterly, 2025-12-31) — Change In Working Capital: 726000.00
BEAT cash_flow (annual, 2025-12-31) — Changes In Cash: 2003000.00
BEAT cash_flow (quarterly, 2025-12-31) — Changes In Cash: 2524000.00
BEAT balance_sheet (annual, 2025-12-31) — Common Stock: 4000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Common Stock: 4000.00
BEAT balance_sheet (annual, 2025-12-31) — Common Stock Equity: 2603000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Common Stock Equity: 2603000.00
BEAT cash_flow (annual, 2025-12-31) — Common Stock Issuance: 16578000.00
BEAT cash_flow (quarterly, 2025-12-31) — Common Stock Issuance: 5834000.00
BEAT balance_sheet (annual, 2025-12-31) — Current Accrued Expenses: 2187000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Current Accrued Expenses: 2187000.00
BEAT balance_sheet (annual, 2025-12-31) — Current Assets: 4685000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Current Assets: 4685000.00
BEAT balance_sheet (annual, 2025-12-31) — Current Liabilities: 3240000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Current Liabilities: 3240000.00
BEAT cash_flow (annual, 2025-12-31) — Depreciation: 40000.00
BEAT cash_flow (quarterly, 2025-12-31) — Depreciation: 17000.00
BEAT cash_flow (annual, 2025-12-31) — Depreciation Amortization Depletion: 40000.00
BEAT cash_flow (quarterly, 2025-12-31) — Depreciation Amortization Depletion: 17000.00
BEAT cash_flow (annual, 2025-12-31) — Depreciation And Amortization: 40000.00
BEAT cash_flow (quarterly, 2025-12-31) — Depreciation And Amortization: 17000.00
BEAT income_statement (annual, 2025-12-31) — Diluted Average Shares: 33710095.00
BEAT income_statement (annual, 2025-12-31) — Diluted EPS: -0.62
BEAT income_statement (annual, 2025-12-31) — Diluted NI Availto Com Stockholders: -21015000.00
BEAT income_statement (quarterly, 2025-12-31) — Diluted NI Availto Com Stockholders: -5302000.00
BEAT income_statement (annual, 2025-12-31) — EBIT: -21139000.00
BEAT income_statement (quarterly, 2025-12-31) — EBIT: -5310000.00
BEAT income_statement (annual, 2025-12-31) — EBITDA: -21099000.00
BEAT income_statement (quarterly, 2025-12-31) — EBITDA: -5293000.00
BEAT cash_flow (annual, 2025-12-31) — End Cash Position: 4436000.00
BEAT cash_flow (quarterly, 2025-12-31) — End Cash Position: 4436000.00
BEAT cash_flow (annual, 2025-12-31) — Financing Cash Flow: 16591000.00
BEAT cash_flow (quarterly, 2025-12-31) — Financing Cash Flow: 5846000.00
BEAT cash_flow (annual, 2025-12-31) — Free Cash Flow: -14588000.00
BEAT cash_flow (quarterly, 2025-12-31) — Free Cash Flow: -3322000.00
BEAT income_statement (annual, 2025-12-31) — General And Administrative Expense: 7689000.00
BEAT income_statement (quarterly, 2025-12-31) — General And Administrative Expense: 1956000.00
BEAT cash_flow (annual, 2025-12-31) — Income Tax Paid Supplemental Data: 0.00
BEAT cash_flow (quarterly, 2025-12-31) — Income Tax Paid Supplemental Data: 0.00
BEAT income_statement (annual, 2025-12-31) — Interest Income: 122000.00
BEAT income_statement (quarterly, 2025-12-31) — Interest Income: 5000.00
BEAT income_statement (annual, 2025-12-31) — Interest Income Non Operating: 122000.00
BEAT income_statement (quarterly, 2025-12-31) — Interest Income Non Operating: 5000.00
BEAT balance_sheet (annual, 2025-12-31) — Inventory: 103000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Inventory: 103000.00
BEAT balance_sheet (annual, 2025-12-31) — Invested Capital: 2603000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Invested Capital: 2603000.00
BEAT cash_flow (annual, 2025-12-31) — Investing Cash Flow: -600000.00
BEAT cash_flow (quarterly, 2025-12-31) — Investing Cash Flow: -416000.00
BEAT cash_flow (annual, 2025-12-31) — Issuance Of Capital Stock: 16578000.00
BEAT cash_flow (quarterly, 2025-12-31) — Issuance Of Capital Stock: 5834000.00
BEAT cash_flow (annual, 2025-12-31) — Net Common Stock Issuance: 16578000.00
BEAT cash_flow (quarterly, 2025-12-31) — Net Common Stock Issuance: 5834000.00
BEAT income_statement (annual, 2025-12-31) — Net Income: -21015000.00
BEAT income_statement (quarterly, 2025-12-31) — Net Income: -5302000.00
BEAT income_statement (annual, 2025-12-31) — Net Income Common Stockholders: -21015000.00
BEAT income_statement (quarterly, 2025-12-31) — Net Income Common Stockholders: -5302000.00
BEAT income_statement (annual, 2025-12-31) — Net Income Continuous Operations: -21015000.00
BEAT income_statement (quarterly, 2025-12-31) — Net Income Continuous Operations: -5302000.00
BEAT income_statement (annual, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -21015000.00
BEAT income_statement (quarterly, 2025-12-31) — Net Income From Continuing And Discontinued Operation: -5302000.00
BEAT income_statement (annual, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -21015000.00
BEAT income_statement (quarterly, 2025-12-31) — Net Income From Continuing Operation Net Minority Interest: -5302000.00
BEAT cash_flow (annual, 2025-12-31) — Net Income From Continuing Operations: -21015000.00
BEAT cash_flow (quarterly, 2025-12-31) — Net Income From Continuing Operations: -5302000.00
BEAT income_statement (annual, 2025-12-31) — Net Income Including Noncontrolling Interests: -21015000.00
BEAT income_statement (quarterly, 2025-12-31) — Net Income Including Noncontrolling Interests: -5302000.00
BEAT income_statement (annual, 2025-12-31) — Net Interest Income: 122000.00
BEAT income_statement (quarterly, 2025-12-31) — Net Interest Income: 5000.00
BEAT cash_flow (annual, 2025-12-31) — Net Investment Purchase And Sale: 0.00
BEAT cash_flow (quarterly, 2025-12-31) — Net Investment Purchase And Sale: 0.00
BEAT income_statement (annual, 2025-12-31) — Net Non Operating Interest Income Expense: 122000.00
BEAT income_statement (quarterly, 2025-12-31) — Net Non Operating Interest Income Expense: 5000.00
BEAT balance_sheet (annual, 2025-12-31) — Net PPE: 1102000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Net PPE: 1102000.00
BEAT cash_flow (annual, 2025-12-31) — Net PPE Purchase And Sale: -600000.00
BEAT cash_flow (quarterly, 2025-12-31) — Net PPE Purchase And Sale: -416000.00
BEAT balance_sheet (annual, 2025-12-31) — Net Tangible Assets: 2603000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Net Tangible Assets: 2603000.00
BEAT income_statement (annual, 2025-12-31) — Normalized EBITDA: -21099000.00
BEAT income_statement (quarterly, 2025-12-31) — Normalized EBITDA: -5293000.00
BEAT income_statement (annual, 2025-12-31) — Normalized Income: -21015000.00
BEAT income_statement (quarterly, 2025-12-31) — Normalized Income: -5302000.00
BEAT cash_flow (annual, 2025-12-31) — Operating Cash Flow: -13988000.00
BEAT cash_flow (quarterly, 2025-12-31) — Operating Cash Flow: -2906000.00
BEAT income_statement (annual, 2025-12-31) — Operating Income: -21139000.00
BEAT income_statement (quarterly, 2025-12-31) — Operating Income: -5310000.00
BEAT income_statement (annual, 2025-12-31) — Operating Revenue: 0.00
BEAT income_statement (quarterly, 2025-12-31) — Operating Revenue: 0.00
BEAT balance_sheet (annual, 2025-12-31) — Ordinary Shares Number: 40117404.00
BEAT balance_sheet (quarterly, 2025-12-31) — Ordinary Shares Number: 40117404.00
BEAT balance_sheet (annual, 2025-12-31) — Other Current Assets: 202000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Other Current Assets: 202000.00
BEAT income_statement (annual, 2025-12-31) — Other Gand A: 7689000.00
BEAT income_statement (quarterly, 2025-12-31) — Other Gand A: 1956000.00
BEAT income_statement (annual, 2025-12-31) — Other Income Expense: 2000.00
BEAT income_statement (quarterly, 2025-12-31) — Other Income Expense: 3000.00
BEAT cash_flow (annual, 2025-12-31) — Other Non Cash Items: 226000.00
BEAT balance_sheet (annual, 2025-12-31) — Other Non Current Assets: 56000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Other Non Current Assets: 56000.00
BEAT income_statement (annual, 2025-12-31) — Other Non Operating Income Expenses: 2000.00
BEAT income_statement (quarterly, 2025-12-31) — Other Non Operating Income Expenses: 3000.00
BEAT balance_sheet (annual, 2025-12-31) — Payables: 1053000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Payables: 1053000.00
BEAT balance_sheet (annual, 2025-12-31) — Payables And Accrued Expenses: 3240000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Payables And Accrued Expenses: 3240000.00
BEAT balance_sheet (annual, 2025-12-31) — Preferred Stock: 0.00
BEAT balance_sheet (quarterly, 2025-12-31) — Preferred Stock: 0.00
BEAT income_statement (annual, 2025-12-31) — Pretax Income: -21015000.00
BEAT income_statement (quarterly, 2025-12-31) — Pretax Income: -5302000.00
BEAT cash_flow (annual, 2025-12-31) — Proceeds From Stock Option Exercised: 13000.00
BEAT cash_flow (quarterly, 2025-12-31) — Proceeds From Stock Option Exercised: 12000.00
BEAT cash_flow (annual, 2025-12-31) — Purchase Of Investment: -3760000.00
BEAT cash_flow (quarterly, 2025-12-31) — Purchase Of Investment: 0.00
BEAT cash_flow (annual, 2025-12-31) — Purchase Of PPE: -600000.00
BEAT cash_flow (quarterly, 2025-12-31) — Purchase Of PPE: -416000.00
BEAT income_statement (annual, 2025-12-31) — Reconciled Depreciation: 40000.00
BEAT income_statement (quarterly, 2025-12-31) — Reconciled Depreciation: 17000.00
BEAT income_statement (annual, 2025-12-31) — Research And Development: 13450000.00
BEAT income_statement (quarterly, 2025-12-31) — Research And Development: 3354000.00
BEAT balance_sheet (annual, 2025-12-31) — Retained Earnings: -77288000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Retained Earnings: -77288000.00
BEAT cash_flow (annual, 2025-12-31) — Sale Of Investment: 3760000.00
BEAT cash_flow (quarterly, 2025-12-31) — Sale Of Investment: 0.00
BEAT income_statement (annual, 2025-12-31) — Selling General And Administration: 7689000.00
BEAT income_statement (quarterly, 2025-12-31) — Selling General And Administration: 1956000.00
BEAT balance_sheet (annual, 2025-12-31) — Share Issued: 40117404.00
BEAT balance_sheet (quarterly, 2025-12-31) — Share Issued: 40117404.00
BEAT cash_flow (annual, 2025-12-31) — Stock Based Compensation: 5147000.00
BEAT cash_flow (quarterly, 2025-12-31) — Stock Based Compensation: 1427000.00
BEAT balance_sheet (annual, 2025-12-31) — Stockholders Equity: 2603000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Stockholders Equity: 2603000.00
BEAT balance_sheet (annual, 2025-12-31) — Tangible Book Value: 2603000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Tangible Book Value: 2603000.00
BEAT income_statement (annual, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BEAT income_statement (quarterly, 2025-12-31) — Tax Effect Of Unusual Items: 0.00
BEAT income_statement (annual, 2025-12-31) — Tax Provision: 0.00
BEAT income_statement (quarterly, 2025-12-31) — Tax Provision: 0.00
BEAT income_statement (annual, 2025-12-31) — Tax Rate For Calcs: 0.00
BEAT income_statement (quarterly, 2025-12-31) — Tax Rate For Calcs: 0.00
BEAT balance_sheet (annual, 2025-12-31) — Total Assets: 5843000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Total Assets: 5843000.00
BEAT balance_sheet (annual, 2025-12-31) — Total Capitalization: 2603000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Total Capitalization: 2603000.00
BEAT balance_sheet (annual, 2025-12-31) — Total Equity Gross Minority Interest: 2603000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Total Equity Gross Minority Interest: 2603000.00
BEAT income_statement (annual, 2025-12-31) — Total Expenses: 21139000.00
BEAT income_statement (quarterly, 2025-12-31) — Total Expenses: 5310000.00
BEAT balance_sheet (annual, 2025-12-31) — Total Liabilities Net Minority Interest: 3240000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Total Liabilities Net Minority Interest: 3240000.00
BEAT balance_sheet (annual, 2025-12-31) — Total Non Current Assets: 1158000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Total Non Current Assets: 1158000.00
BEAT balance_sheet (annual, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
BEAT balance_sheet (quarterly, 2025-12-31) — Total Non Current Liabilities Net Minority Interest: 0.00
BEAT income_statement (annual, 2025-12-31) — Total Operating Income As Reported: -21139000.00
BEAT income_statement (quarterly, 2025-12-31) — Total Operating Income As Reported: -5310000.00
BEAT balance_sheet (annual, 2025-12-31) — Working Capital: 1445000.00
BEAT balance_sheet (quarterly, 2025-12-31) — Working Capital: 1445000.00
BEAT income_statement (quarterly, 2026-03-31) — +Operating Expense: 4716000.00
BEAT income_statement (quarterly, 2026-03-31) — +Total Revenue: 0.00
BEAT balance_sheet (quarterly, 2026-03-31) — Accounts Payable: 747000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Accumulated Depreciation: -71000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Additional Paid In Capital: 82619000.00
BEAT income_statement (quarterly, 2026-03-31) — Basic Average Shares: 40588385.00
BEAT income_statement (quarterly, 2026-03-31) — Basic EPS: -0.12
BEAT cash_flow (quarterly, 2026-03-31) — Beginning Cash Position: 4436000.00
BEAT cash_flow (quarterly, 2026-03-31) — Capital Expenditure: -246000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Capital Stock: 4000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Cash And Cash Equivalents: 2039000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Cash Cash Equivalents And Short Term Investments: 2039000.00
BEAT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Financing Activities: 1515000.00
BEAT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Investing Activities: -246000.00
BEAT cash_flow (quarterly, 2026-03-31) — Cash Flow From Continuing Operating Activities: -3610000.00
BEAT cash_flow (quarterly, 2026-03-31) — Change In Inventory: -30000.00
BEAT cash_flow (quarterly, 2026-03-31) — Change In Payables And Accrued Expense: -60000.00
BEAT cash_flow (quarterly, 2026-03-31) — Change In Prepaid Assets: -61000.00
BEAT cash_flow (quarterly, 2026-03-31) — Change In Working Capital: -151000.00
BEAT cash_flow (quarterly, 2026-03-31) — Changes In Cash: -2341000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Common Stock: 4000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Common Stock Equity: 635000.00
BEAT cash_flow (quarterly, 2026-03-31) — Common Stock Issuance: 1515000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Current Accrued Expenses: 2547000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Current Assets: 2435000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Current Liabilities: 3294000.00
BEAT cash_flow (quarterly, 2026-03-31) — Depreciation: 24000.00
BEAT cash_flow (quarterly, 2026-03-31) — Depreciation Amortization Depletion: 24000.00
BEAT cash_flow (quarterly, 2026-03-31) — Depreciation And Amortization: 24000.00
BEAT income_statement (quarterly, 2026-03-31) — Diluted Average Shares: 40588385.00
BEAT income_statement (quarterly, 2026-03-31) — Diluted EPS: -0.12
BEAT income_statement (quarterly, 2026-03-31) — Diluted NI Availto Com Stockholders: -4700000.00
BEAT income_statement (quarterly, 2026-03-31) — EBIT: -4716000.00
BEAT income_statement (quarterly, 2026-03-31) — EBITDA: -4692000.00
BEAT cash_flow (quarterly, 2026-03-31) — End Cash Position: 2095000.00
BEAT cash_flow (quarterly, 2026-03-31) — Financing Cash Flow: 1515000.00
BEAT cash_flow (quarterly, 2026-03-31) — Free Cash Flow: -3856000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Gross PPE: 1509000.00
BEAT cash_flow (quarterly, 2026-03-31) — Income Tax Paid Supplemental Data: 0.00
BEAT income_statement (quarterly, 2026-03-31) — Interest Income: 16000.00
BEAT income_statement (quarterly, 2026-03-31) — Interest Income Non Operating: 16000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Inventory: 133000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Invested Capital: 635000.00
BEAT cash_flow (quarterly, 2026-03-31) — Investing Cash Flow: -246000.00
BEAT cash_flow (quarterly, 2026-03-31) — Issuance Of Capital Stock: 1515000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Machinery Furniture Equipment: 276000.00
BEAT cash_flow (quarterly, 2026-03-31) — Net Common Stock Issuance: 1515000.00
BEAT income_statement (quarterly, 2026-03-31) — Net Income: -4700000.00
BEAT income_statement (quarterly, 2026-03-31) — Net Income Common Stockholders: -4700000.00
BEAT income_statement (quarterly, 2026-03-31) — Net Income Continuous Operations: -4700000.00
BEAT income_statement (quarterly, 2026-03-31) — Net Income From Continuing And Discontinued Operation: -4700000.00
BEAT income_statement (quarterly, 2026-03-31) — Net Income From Continuing Operation Net Minority Interest: -4700000.00
BEAT cash_flow (quarterly, 2026-03-31) — Net Income From Continuing Operations: -4700000.00
BEAT income_statement (quarterly, 2026-03-31) — Net Income Including Noncontrolling Interests: -4700000.00
BEAT income_statement (quarterly, 2026-03-31) — Net Interest Income: 16000.00
BEAT cash_flow (quarterly, 2026-03-31) — Net Investment Purchase And Sale: 0.00
BEAT income_statement (quarterly, 2026-03-31) — Net Non Operating Interest Income Expense: 16000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Net PPE: 1438000.00
BEAT cash_flow (quarterly, 2026-03-31) — Net PPE Purchase And Sale: -246000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Net Tangible Assets: 635000.00
BEAT income_statement (quarterly, 2026-03-31) — Normalized EBITDA: -4692000.00
BEAT income_statement (quarterly, 2026-03-31) — Normalized Income: -4700000.00
BEAT cash_flow (quarterly, 2026-03-31) — Operating Cash Flow: -3610000.00
BEAT income_statement (quarterly, 2026-03-31) — Operating Income: -4716000.00
BEAT income_statement (quarterly, 2026-03-31) — Operating Revenue: 0.00
BEAT balance_sheet (quarterly, 2026-03-31) — Ordinary Shares Number: 41131835.00
BEAT balance_sheet (quarterly, 2026-03-31) — Other Current Assets: 263000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Other Non Current Assets: 56000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Other Properties: 1233000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Payables: 747000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Payables And Accrued Expenses: 3294000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Preferred Stock: 0.00
BEAT income_statement (quarterly, 2026-03-31) — Pretax Income: -4700000.00
BEAT cash_flow (quarterly, 2026-03-31) — Purchase Of Investment: 0.00
BEAT cash_flow (quarterly, 2026-03-31) — Purchase Of PPE: -246000.00
BEAT income_statement (quarterly, 2026-03-31) — Reconciled Depreciation: 24000.00
BEAT income_statement (quarterly, 2026-03-31) — Research And Development: 2370000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Retained Earnings: -81988000.00
BEAT income_statement (quarterly, 2026-03-31) — Selling General And Administration: 2346000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Share Issued: 41131835.00
BEAT cash_flow (quarterly, 2026-03-31) — Stock Based Compensation: 1217000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Stockholders Equity: 635000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Tangible Book Value: 635000.00
BEAT income_statement (quarterly, 2026-03-31) — Tax Effect Of Unusual Items: 0.00
BEAT income_statement (quarterly, 2026-03-31) — Tax Provision: 0.00
BEAT income_statement (quarterly, 2026-03-31) — Tax Rate For Calcs: 0.00
BEAT balance_sheet (quarterly, 2026-03-31) — Total Assets: 3929000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Total Capitalization: 635000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Total Equity Gross Minority Interest: 635000.00
BEAT income_statement (quarterly, 2026-03-31) — Total Expenses: 4716000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Total Liabilities Net Minority Interest: 3294000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Total Non Current Assets: 1494000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Total Non Current Liabilities Net Minority Interest: 0.00
BEAT income_statement (quarterly, 2026-03-31) — Total Operating Income As Reported: -4716000.00
BEAT balance_sheet (quarterly, 2026-03-31) — Working Capital: -859000.00
BEBE balance_sheet (quarterly, 2025-07-31) — Additional Paid In Capital: 24425.00
BEBE balance_sheet (quarterly, 2025-07-31) — Capital Stock: 575.00
BEBE balance_sheet (quarterly, 2025-07-31) — Common Stock: 575.00
BEBE balance_sheet (quarterly, 2025-07-31) — Common Stock Equity: 11480.00
BEBE balance_sheet (quarterly, 2025-07-31) — Current Accrued Expenses: 203520.00
BEBE balance_sheet (quarterly, 2025-07-31) — Current Assets: 25000.00
BEBE balance_sheet (quarterly, 2025-07-31) — Current Liabilities: 203520.00
BEBE balance_sheet (quarterly, 2025-07-31) — Invested Capital: 11480.00
BEBE balance_sheet (quarterly, 2025-07-31) — Net Tangible Assets: 11480.00
BEBE balance_sheet (quarterly, 2025-07-31) — Non Current Deferred Assets: 190000.00
BEBE balance_sheet (quarterly, 2025-07-31) — Ordinary Shares Number: 20000000.00
BEBE balance_sheet (quarterly, 2025-07-31) — Other Receivables: 25000.00
BEBE balance_sheet (quarterly, 2025-07-31) — Payables And Accrued Expenses: 203520.00
BEBE balance_sheet (quarterly, 2025-07-31) — Preferred Stock: 0.00
BEBE balance_sheet (quarterly, 2025-07-31) — Receivables: 25000.00
BEBE balance_sheet (quarterly, 2025-07-31) — Retained Earnings: -13520.00
BEBE balance_sheet (quarterly, 2025-07-31) — Share Issued: 20000000.00
BEBE balance_sheet (quarterly, 2025-07-31) — Stockholders Equity: 11480.00
BEBE balance_sheet (quarterly, 2025-07-31) — Tangible Book Value: 11480.00
BEBE balance_sheet (quarterly, 2025-07-31) — Total Assets: 215000.00
BEBE balance_sheet (quarterly, 2025-07-31) — Total Capitalization: 11480.00
BEBE balance_sheet (quarterly, 2025-07-31) — Total Equity Gross Minority Interest: 11480.00
BEBE balance_sheet (quarterly, 2025-07-31) — Total Liabilities Net Minority Interest: 203520.00
BEBE balance_sheet (quarterly, 2025-07-31) — Total Non Current Assets: 190000.00
BEBE balance_sheet (quarterly, 2025-07-31) — Total Non Current Liabilities Net Minority Interest: 0.00
BEBE balance_sheet (quarterly, 2025-07-31) — Working Capital: -178520.00
BEBE income_statement (quarterly, 2025-09-30) — +Operating Expense: 56176.00
BEBE income_statement (quarterly, 2025-09-30) — +Total Revenue: 0.00
BEBE balance_sheet (quarterly, 2025-09-30) — Accounts Payable: 1654.00
BEBE balance_sheet (quarterly, 2025-09-30) — Additional Paid In Capital: 24425.00
BEBE income_statement (quarterly, 2025-09-30) — Basic Average Shares: 20000000.00
BEBE income_statement (quarterly, 2025-09-30) — Basic EPS: 0.00
BEBE cash_flow (quarterly, 2025-09-30) — Beginning Cash Position: 0.00
BEBE balance_sheet (quarterly, 2025-09-30) — Capital Stock: 575.00
BEBE balance_sheet (quarterly, 2025-09-30) — Cash And Cash Equivalents: 7398.00
BEBE balance_sheet (quarterly, 2025-09-30) — Cash Cash Equivalents And Short Term Investments: 7398.00
BEBE balance_sheet (quarterly, 2025-09-30) — Cash Financial: 7398.00
BEBE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Financing Activities: 14400.00
BEBE cash_flow (quarterly, 2025-09-30) — Cash Flow From Continuing Operating Activities: -7002.00
BEBE cash_flow (quarterly, 2025-09-30) — Change In Account Payable: 1654.00
BEBE cash_flow (quarterly, 2025-09-30) — Change In Accrued Expense: 47520.00
BEBE cash_flow (quarterly, 2025-09-30) — Change In Payable: 1654.00
BEBE cash_flow (quarterly, 2025-09-30) — Change In Payables And Accrued Expense: 49174.00
BEBE cash_flow (quarterly, 2025-09-30) — Change In Working Capital: 49174.00
BEBE cash_flow (quarterly, 2025-09-30) — Changes In Cash: 7398.00
BEBE balance_sheet (quarterly, 2025-09-30) — Common Stock: 575.00
BEBE balance_sheet (quarterly, 2025-09-30) — Common Stock Equity: -31176.00
BEBE balance_sheet (quarterly, 2025-09-30) — Current Accrued Expenses: 544685.00
BEBE balance_sheet (quarterly, 2025-09-30) — Current Assets: 7398.00
BEBE balance_sheet (quarterly, 2025-09-30) — Current Debt: 17500.00
BEBE balance_sheet (quarterly, 2025-09-30) — Current Debt And Capital Lease Obligation: 17500.00
BEBE balance_sheet (quarterly, 2025-09-30) — Current Liabilities: 563839.00
BEBE income_statement (quarterly, 2025-09-30) — Diluted Average Shares: 20000000.00
BEBE income_statement (quarterly, 2025-09-30) — Diluted EPS: 0.00
BEBE income_statement (quarterly, 2025-09-30) — Diluted NI Availto Com Stockholders: -56176.00
BEBE income_statement (quarterly, 2025-09-30) — EBIT: -56176.00
BEBE income_statement (quarterly, 2025-09-30) — EBITDA: -56176.00
BEBE cash_flow (quarterly, 2025-09-30) — End Cash Position: 7398.00
BEBE cash_flow (quarterly, 2025-09-30) — Financing Cash Flow: 14400.00
BEBE cash_flow (quarterly, 2025-09-30) — Free Cash Flow: -7002.00
BEBE income_statement (quarterly, 2025-09-30) — General And Administrative Expense: 56176.00
BEBE balance_sheet (quarterly, 2025-09-30) — Invested Capital: -13676.00
BEBE cash_flow (quarterly, 2025-09-30) — Issuance Of Debt: 15000.00
BEBE balance_sheet (quarterly, 2025-09-30) — Net Debt: 10102.00
BEBE income_statement (quarterly, 2025-09-30) — Net Income: -56176.00
BEBE income_statement (quarterly, 2025-09-30) — Net Income Common Stockholders: -56176.00
BEBE income_statement (quarterly, 2025-09-30) — Net Income Continuous Operations: -56176.00
BEBE income_statement (quarterly, 2025-09-30) — Net Income From Continuing And Discontinued Operation: -56176.00
BEBE income_statement (quarterly, 2025-09-30) — Net Income From Continuing Operation Net Minority Interest: -56176.00
BEBE cash_flow (quarterly, 2025-09-30) — Net Income From Continuing Operations: -56176.00
BEBE income_statement (quarterly, 2025-09-30) — Net Income Including Noncontrolling Interests: -56176.00
BEBE cash_flow (quarterly, 2025-09-30) — Net Issuance Payments Of Debt: 15000.00
BEBE cash_flow (quarterly, 2025-09-30) — Net Other Financing Charges: -600.00
BEBE cash_flow (quarterly, 2025-09-30) — Net Short Term Debt Issuance: 15000.00
BEBE balance_sheet (quarterly, 2025-09-30) — Net Tangible Assets: -31176.00
BEBE balance_sheet (quarterly, 2025-09-30) — Non Current Deferred Assets: 525265.00
BEBE income_statement (quarterly, 2025-09-30) — Normalized EBITDA: -56176.00
BEBE income_statement (quarterly, 2025-09-30) — Normalized Income: -56176.00
BEBE cash_flow (quarterly, 2025-09-30) — Operating Cash Flow: -7002.00
BEBE income_statement (quarterly, 2025-09-30) — Operating Income: -56176.00
BEBE income_statement (quarterly, 2025-09-30) — Operating Revenue: 0.00
BEBE balance_sheet (quarterly, 2025-09-30) — Ordinary Shares Number: 20000000.00
BEBE balance_sheet (quarterly, 2025-09-30) — Other Current Borrowings: 17500.00
BEBE income_statement (quarterly, 2025-09-30) — Other Gand A: 56176.00
BEBE balance_sheet (quarterly, 2025-09-30) — Payables: 1654.00
BEBE balance_sheet (quarterly, 2025-09-30) — Payables And Accrued Expenses: 546339.00
BEBE balance_sheet (quarterly, 2025-09-30) — Preferred Stock: 0.00
BEBE income_statement (quarterly, 2025-09-30) — Pretax Income: -56176.00